The "Enzymatic DNA Synthesis Market by Service, by Application, by End-User, and By Region" report has been added to ...

Esphera SynBio, a pre-clinical stage synthetic biology company, today announced a new project aimed at advancing next-generation mRNA vaccines. Using its proprietary technology, Esphera SynBio causes ...

Touchlight, an innovation-driven Contract Development and Manufacturing Organisation (CDMO), today announced that its facility in Hampton UK has received GMP certification. As a result, Touchlight ...

STONY BROOK, NY / ACCESSWIRE / / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in ...

Signals Start of New Commercialization Phase for LineaRx Subsidiary -- Company Negotiating GMP Supply Agreement -- Company Reaffirms Strategic Restructuring Timeline - STONY BROOK, NY / ACCESSWIRE / ...

Overview: In Uganda alone, frequent FMD outbreaks have resulted in losses amounting to millions annually. Between 2015 and ...

January 2025 - 4basebio PLC (AIM: 4BB) (“4basebio” or the “Company”), which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, ...

Imagine you're a scientist, tasked with the challenge of rapidly producing large quantities of high-quality messenger RNA (mRNA) for use in cutting-edge medical treatments. Where do you even start?

Here, the synthetic mRNA encoding tumour-associated or tumour-specific antigens can be delivered through autologous dendritic cells engineered with mRNA ex vivo or through formulated or non ...

NPR's Juana Summers talks with Jessica Yung and Emily Kwong of Short Wave about the physics of hula hooping, why some vaccines last longer than others, and a few moon launches to watch for in 2025.